The Ticker / Macrocure Shares Plunge After Report of Failed Clinical Trial

Delta Galil boosts third-quarter profits; TASE to delay index adjustments until reforms are enacted; Tel Aviv shares turn higher, boosted by pharmaceuticals

comments Print
Macrocure shares plunge after report of failed clinical trial